The Rosemont Criteria Can Predict the Pain Response to Pancreatic Enzyme Supplementation in Patients with Suspected Chronic Pancreatitis Undergoing Endoscopic Ultrasound
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The Rosemont classifi cation system was designed to standardize the endosonographic assessment of chronic pancreatitis. To determine whether the Rosemont classifi cation system can predict the response to pancreatic enzyme supplementation in patients undergoing endoscopic ultrasound (EUS) evaluation of suspected chronic pancreatitis. Methods: Sixty-fi ve patients were included with abdominal pain undergoing endosonography for suspected chronic pancreatitis were included. Patients completed a questionnaire for evaluation of their abdominal pain. Group 1 (n=13) had EUS fi ndings consistent with or suggestive of chronic pancreatitis. Group 2 (n=45) had EUS fi ndings that were normal or indeterminate in the Rosemont classifi cation system. Patients were given pancreatic enzyme supplementation and then given a follow-up pain questionnaire for a mean of 37 days subsequent to EUS regarding the change in pain. Results: Group 1 patients were more likely to have a response to pancreatic enzymes (62% vs 24%, p= 0.012)and a decrease in their pain scale ratings (2.62 vs 0.29,p=0.01). Computed tomography fi ndings of chronic pancreatitis and narcotic use did not predict the response to pancreatic enzyme supplementation. The individual Rosemont criteria of hyperechoic foci with shadowing (p=0.03), lobularity (p=0.02), and stranding (p=0.001) were associated with improvement of pain after treatment. Conclusions: The Rosemont classification system can identify patients who are more likely to have improvement in abdominal pain after treatment with pancreatic enzyme supplementation.
Abstract
Background/Aims: The Rosemont classifi cation system was designed to standardize the endosonographic assessment of chronic pancreatitis. To determine whether the Rosemont classifi cation system can predict the response to pancreatic enzyme supplementation in patients undergoing endoscopic ultrasound (EUS) evaluation of suspected chronic pancreatitis. Methods: Sixty-fi ve patients were included with abdominal pain undergoing endosonography for suspected chronic pancreatitis were included. Patients completed a questionnaire for evaluation of their abdominal pain. Group 1 (n=13) had EUS fi ndings consistent with or suggestive of chronic pancreatitis. Group 2 (n=45) had EUS fi ndings that were normal or indeterminate in the Rosemont classifi cation system. Patients were given pancreatic enzyme supplementation and then given a follow-up pain questionnaire for a mean of 37 days subsequent to EUS regarding the change in pain. Results: Group 1 patients were more likely to have a response to pancreatic enzymes (62% vs 24%, p= 0.012)and a decrease in their pain scale ratings (2.62 vs 0.29,p=0.01). Computed tomography fi ndings of chronic pancreatitis and narcotic use did not predict the response to pancreatic enzyme supplementation. The individual Rosemont criteria of hyperechoic foci with shadowing (p=0.03), lobularity (p=0.02), and stranding (p=0.001) were associated with improvement of pain after treatment. Conclusions: The Rosemont classification system can identify patients who are more likely to have improvement in abdominal pain after treatment with pancreatic enzyme supplementation.
참고문헌 (17)
- Etemad B, "Chronic pancreatitis: diagnosis, classification, and new genetic developments", Gastroenterology, 120, pp.682~707 (2001)
- Drewes AM, "Pain in chronic pancreatitis: the role of neuropathic pain mechanisms", Gut, 57, pp.1616~1627 (2008)
- Witt H, "Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy", Gastroenterology, 132, pp.1557~1573 (2007)
- Green GM, "Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats", Proc Soc Exp Biol Med, 140, pp.6~12 (1972)
- Ihse I, "Effects of intestinal amylase and trypsin on pancreatic secretion in the pig", Scand J Gastroenterol, 14, pp.1009~1013 (1979)
- Isaksson G, "Pain reduction by an oral pancreatic enzymepreparation in chronic pancreatitis", Dig Dis Sci, 28, pp.97~102 (1983)
- Slaff J, "Proteasespecific suppression of pancreatic exocrine secretion", Gastroenterology, 87, pp.44~52 (1984)
- Halgreen H, "Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis", Scand J Gastroenterol, 21, pp.104~108 (1986)
- Mössner J, "Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial", Digestion, 53, pp.54~66 (1992)
- Malesci A, "No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis", Scand J Gastroenterol, 30, pp.392~398 (1995)
- Wallace MB, "Endoscopic ultrasound in the evaluation and treatment of chronic pancreatitis", Pancreas, 23, pp.26~35 (2001)
- Chong AK, "Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology", Gastrointest Endosc, 65, pp.808~814 (2007)
- Catalano MF, "EUS-based criteria for the diagnosis of chronicpancreatitis: the Rosemont classification", Gastrointest Endosc, 69, pp.1251~1261 (2009)
- van Esch AA, "Pharmacological management of pain in chronic pancreatitis", Dig Liver Dis, 38, pp.518~526 (2006)
- Catalano MF, "Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis", Gastrointest Endosc, 48, pp.11~17 (1998)
- Wallace MB, "The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers", Gastrointest Endosc, 53, pp.294~299 (2001)
- Stevens T, "Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis", Gastrointest Endosc, (71), pp.519~526 (2010)